{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-034149","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2026-05-12T20:33:51+00:00","discovered_at":"2026-05-12T20:35:00.311380+00:00","generated_at":"2026-05-12T20:35:45.356735+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sanuwave Q1 rev $9.6M (+3.1% YoY); net loss $1.4M; guides Q2 growth 10-15%","bullets":["Q1 revenue $9.6M, up 3.1% from $9.3M YoY; gross margin 77.3% vs 79.0%.","GAAP operating loss $1.1M, a $1.7M swing from $0.6M operating income YoY.","Ultramist consumables revenue $6.7M, up 15% YoY; set new all-time unit volume record.","Adjusted EBITDA $1.1M vs $2.3M YoY; net loss $1.4M, improved from $6.1M loss (prior year had $4.9M non-cash derivative loss).","Guides Q2 2026 revenue $11.1-11.6M (10-15% growth); reaffirms FY 2026 revenue $51-55M (16-25% growth)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-034149","json":"https://secwatch.observer/filing/0001628280-26-034149.json","markdown":"https://secwatch.observer/filing/0001628280-26-034149.md","text":"https://secwatch.observer/filing/0001628280-26-034149.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/0001628280-26-034149-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/snwv-20260512.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T20:35:45.356735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f5b86df785908add4033c8b4d69ae200b398bd2","claim":"SANUWAVE Health, Inc. reported the three months ended March 31, 2026 results: revenue $9.6 million. Guidance reaffirmed.","evidence_excerpt":"Q1 2026 revenues were $9.6 million, up 3.1% from $9.3 million in Q1 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026034149/0001628280-26-034149-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2026"},{"label":"Revenue","value":"$9.6 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}